Metalidis C et al. |
Expression of CYP3A5 and P-glycoprotein in renal allografts with histological signs of calcineurin inhibitor nephrotoxicity. |
2011 |
Transplantation |
pmid:21544031
|
Shihab FS et al. |
Conversion from cyclosporine to tacrolimus in patients at risk for chronic renal allograft failure: 60-month results of the CRAF Study. |
2008 |
Transplantation |
pmid:18475181
|
Ekberg H |
Calcineurin inhibitor sparing in renal transplantation. |
2008 |
Transplantation |
pmid:18813097
|
Fischer L et al. |
Three-year Outcomes in De Novo Liver Transplant Patients Receiving Everolimus With Reduced Tacrolimus: Follow-Up Results From a Randomized, Multicenter Study. |
2015 |
Transplantation |
pmid:26151607
|
First MR |
Transplantation in the nineties. |
1992 |
Transplantation |
pmid:1370734
|
Gjertson DW et al. |
The relative effects of FK506 and cyclosporine on short- and long-term kidney graft survival. |
1995 |
Transplantation |
pmid:8545861
|
First MR and Fitzsimmons WE |
New drugs to improve transplant outcomes. |
2004 |
Transplantation |
pmid:15201693
|
Migita K et al. |
FK506 markedly enhances apoptosis of antigen-stimulated peripheral T cells by down-regulation of Bcl-xL. |
1999 |
Transplantation |
pmid:10532544
|
Leroy-Matheron C et al. |
Inhibitor against coagulation factor V after liver transplantation. |
1999 |
Transplantation |
pmid:10532550
|
Nakamura Y et al. |
Acceptance of islet allografts in the liver of mice by blockade of an inducible costimulator. |
2003 |
Transplantation |
pmid:12717187
|
Calmus Y et al. |
Assessing renal function with daclizumab induction and delayed tacrolimus introduction in liver transplant recipients. |
2010 |
Transplantation |
pmid:20495510
|
Ouyang J et al. |
Effect of a novel inducible nitric oxide synthase inhibitor in prevention of rat chronic aortic rejections. |
2005 |
Transplantation |
pmid:15912108
|
Abbott KC et al. |
New-onset gout after kidney transplantation: incidence, risk factors and implications. |
2005 |
Transplantation |
pmid:16340779
|
Villanueva G and Baldwin D |
Rosiglitazone therapy of posttransplant diabetes mellitus. |
2005 |
Transplantation |
pmid:16340782
|
Koneru B et al. |
Blood transfusions in liver recipients: a conundrum or a clear benefit in the cyclosporine/tacrolimus era? |
1997 |
Transplantation |
pmid:9197350
|
Sugitani A et al. |
En bloc pancreas and kidney transplantation in a patient with limited vascular access. |
1997 |
Transplantation |
pmid:9197366
|
Shihab FS et al. |
Donor preconditioning with a calcineurin inhibitor improves outcome in rat syngeneic kidney transplantation. |
2009 |
Transplantation |
pmid:19202436
|
Bayer ND et al. |
Association of metabolic syndrome with development of new-onset diabetes after transplantation. |
2010 |
Transplantation |
pmid:20724958
|
Metcalfe SM and Richards FM |
Cyclosporine, FK506, and rapamycin. Some effects on early activation events in serum-free, mitogen-stimulated mouse spleen cells. |
1990 |
Transplantation |
pmid:1691537
|
Ravindran VK et al. |
Insulin hyposecretion in nondiabetic, tacrolimus-treated renal transplant recipients more than 6 months posttransplantation. |
2009 |
Transplantation |
pmid:19543067
|
Morrissey PE et al. |
Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria. |
1997 |
Transplantation |
pmid:9089224
|
Kiuchi T et al. |
A hepatic graft tuberculosis transmitted from a living-related donor. |
1997 |
Transplantation |
pmid:9089234
|
Ericzon BG et al. |
The effect of FK506 treatment on pancreaticoduodenal allotransplantation in the primate. |
1992 |
Transplantation |
pmid:1376501
|
Heilman RL et al. |
Impact of early conversion from tacrolimus to sirolimus on chronic allograft changes in kidney recipients on rapid steroid withdrawal. |
2012 |
Transplantation |
pmid:22067270
|
Sheiner PA et al. |
Increased risk of early rejection correlates with recovery of CD3 cell count after liver transplant in patients receiving OKT3 induction. |
1997 |
Transplantation |
pmid:9355846
|
Karlsson H and Nässberger L |
FK506 suppresses the mitogen-induced increase in lymphocyte adhesiveness to endothelial cells, but does not affect endothelial cell activation in response to inflammatory stimuli. |
1997 |
Transplantation |
pmid:9355847
|
Mourad G et al. |
Incidence of Posttransplantation Diabetes Mellitus in De Novo Kidney Transplant Recipients Receiving Prolonged-Release Tacrolimus-Based Immunosuppression With 2 Different Corticosteroid Minimization Strategies: ADVANCE, A Randomized Controlled Trial. |
2017 |
Transplantation |
pmid:27547871
|
Tanabe M et al. |
Combined immunosuppressive therapy with low dose FK506 and antimetabolites in rat allogeneic heart transplantation. |
1994 |
Transplantation |
pmid:7518619
|
Takaya S et al. |
Liver transplantation in positive cytotoxic crossmatch cases using FK506, high-dose steroids, and prostaglandin E1. |
1992 |
Transplantation |
pmid:1279851
|
Wasik M et al. |
Effect of FK506 versus cyclosporine on human natural and antibody-dependent cytotoxicity reactions in vitro. |
1991 |
Transplantation |
pmid:1702910
|
Carroll PB et al. |
Effect of the immunosuppressant FK506 on glucose-induced insulin secretion from adult rat islets of Langerhans. |
1991 |
Transplantation |
pmid:1702911
|
Starzl TE et al. |
Hepatotrophic effects of FK506 in dogs. |
1991 |
Transplantation |
pmid:1702912
|
David-Neto E et al. |
Longitudinal Pharmacokinetics of Tacrolimus in Elderly Compared With Younger Recipients in the First 6 Months After Renal Transplantation. |
2017 |
Transplantation |
pmid:27482958
|
Marcén R et al. |
Lumbar bone mineral density in renal transplant patients on neoral and tacrolimus: a four-year prospective study. |
2006 |
Transplantation |
pmid:16570003
|
Heilman RL et al. |
Results of a prospective randomized trial of sirolimus conversion in kidney transplant recipients on early corticosteroid withdrawal. |
2011 |
Transplantation |
pmid:21775930
|
Ciancio G et al. |
A randomized long-term trial of tacrolimus/sirolimus versus tacrolimums/mycophenolate versus cyclosporine/sirolimus in renal transplantation: three-year analysis. |
2006 |
Transplantation |
pmid:16570006
|
Bellon H et al. |
The Effect of Immunosuppression on Airway Integrity. |
2017 |
Transplantation |
pmid:28471870
|
Barten MJ et al. |
Synergistic effects of sirolimus with cyclosporine and tacrolimus: analysis of immunosuppression on lymphocyte proliferation and activation in rat whole blood. |
2004 |
Transplantation |
pmid:15114077
|
Reddy KS et al. |
Simultaneous kidney-pancreas transplantation without antilymphocyte induction. |
2000 |
Transplantation |
pmid:10653379
|
Sood P et al. |
Management and outcome of BK viremia in renal transplant recipients: a prospective single-center study. |
2012 |
Transplantation |
pmid:23018881
|
Jain A et al. |
Conversion to neoral for neurotoxicity after primary adult liver transplantation under tacrolimus. |
2000 |
Transplantation |
pmid:10653398
|
Jevnikar A et al. |
Five-year study of tacrolimus as secondary intervention versus continuation of cyclosporine in renal transplant patients at risk for chronic renal allograft failure. |
2008 |
Transplantation |
pmid:18852662
|
Yamazaki S et al. |
Transplantation-related thrombotic microangiopathy triggered by preemptive therapy for hepatitis C virus infection. |
2008 |
Transplantation |
pmid:18852671
|
Kiuchi T |
CNIs: immediate benefits but storing problems for the future? |
2008 |
Transplantation |
pmid:18946338
|
Couzi L et al. |
Immunological monitoring of calcineurin inhibitors for predicting cytomegalovirus infection in kidney transplant recipients. |
2008 |
Transplantation |
pmid:18946343
|
Horner BM et al. |
Recipient damage after musculocutaneous transplant rejection. |
2008 |
Transplantation |
pmid:18946349
|
Stevens RB et al. |
A randomized 2×2 factorial trial, part 1: single-dose rabbit antithymocyte globulin induction may improve renal transplantation outcomes. |
2015 |
Transplantation |
pmid:25083614
|
Ravaioli M et al. |
Immunosuppression Modifications Based on an Immune Response Assay: Results of a Randomized, Controlled Trial. |
2015 |
Transplantation |
pmid:25757214
|
Shaffer D et al. |
Normal pancreas allograft function following simultaneous pancreas kidney transplantation after rescue therapy with tacrolimus (FK506). |
1995 |
Transplantation |
pmid:7535958
|
Yoshimura N et al. |
Effect of a new immunosuppressive agent, FK506, on human lymphocyte responses in vitro. II. Inhibition of the production of IL-2 and gamma-IFN, but not B cell-stimulating factor 2. |
1989 |
Transplantation |
pmid:2465593
|
Ninova D et al. |
Acute nephrotoxicity of tacrolimus and sirolimus in renal isografts: differential intragraft expression of transforming growth factor-beta1 and alpha-smooth muscle actin. |
2004 |
Transplantation |
pmid:15316360
|
Ciancio G et al. |
The use of Campath-1H as induction therapy in renal transplantation: preliminary results. |
2004 |
Transplantation |
pmid:15316372
|
Naesens M and Sarwal MM |
Monitoring calcineurin inhibitor therapy: localizing the moving target. |
2010 |
Transplantation |
pmid:20458272
|
Kaufman DB et al. |
The successful use of tacrolimus (FK506) in a pancreas/kidney transplant recipient with recurrent cyclosporine-associated hemolytic uremic syndrome. |
1995 |
Transplantation |
pmid:7541579
|
Watson MJ et al. |
Renal function impacts outcomes after intestinal transplantation. |
2008 |
Transplantation |
pmid:18622288
|
Herzog D et al. |
Normal glomerular filtration rate in long-term follow-up of children after orthotopic liver transplantation. |
2006 |
Transplantation |
pmid:16534467
|
Ochiai T et al. |
Effects of combination treatment with FK506 and cyclosporine on survival time and vascular changes in renal-allograft-recipient dogs. |
1989 |
Transplantation |
pmid:2474209
|
Iwata H et al. |
Suppression of allograft responses by combining donor alloantigen-specific intravenous presensitization with suboptimal doses of FK506. |
1993 |
Transplantation |
pmid:7687396
|
Roelen DL et al. |
Differential inhibition of primed alloreactive CTLs in vitro by clinically used concentrations of cyclosporine and FK506. |
1993 |
Transplantation |
pmid:7687397
|
McLaren A |
Tacrolimus pharmacogenetics: bringing the laboratory into the clinic. |
2003 |
Transplantation |
pmid:14705621
|
McDiarmid SV et al. |
Factors affecting growth after pediatric liver transplantation. |
1999 |
Transplantation |
pmid:10030286
|
Florescu DF et al. |
Adenovirus infections in pediatric small bowel transplant recipients. |
2010 |
Transplantation |
pmid:20467354
|
Amundsen R et al. |
Rimonabant affects cyclosporine a, but not tacrolimus pharmacokinetics in renal transplant recipients. |
2009 |
Transplantation |
pmid:19384170
|
Eckhoff DE et al. |
The safety and efficacy of a two-dose daclizumab (zenapax) induction therapy in liver transplant recipients. |
2000 |
Transplantation |
pmid:10830224
|
Jun KR et al. |
Tacrolimus concentrations in relation to CYP3A and ABCB1 polymorphisms among solid organ transplant recipients in Korea. |
2009 |
Transplantation |
pmid:19384171
|
Curran CF et al. |
Acute overdoses of tacrolimus. |
1996 |
Transplantation |
pmid:8932293
|
Roberts CA et al. |
Asymmetric cardiac hypertrophy at autopsy in patients who received FK506 (tacrolimus) or cyclosporine A after liver transplant. |
2002 |
Transplantation |
pmid:12364862
|
Vafadari R et al. |
Inhibitory effect of tacrolimus on p38 mitogen-activated protein kinase signaling in kidney transplant recipients measured by whole-blood phosphospecific flow cytometry. |
2012 |
Transplantation |
pmid:22643331
|
Hanto DW and Chudzinski R |
What does the CONVERT trial really tell us about conversion from calcineurin inhibitors to sirolimus? |
2009 |
Transplantation |
pmid:19155968
|
Morales JM et al. |
Improved renal function, with similar proteinuria, after two years of early tacrolimus withdrawal from a regimen of sirolimus plus tacrolimus. |
2008 |
Transplantation |
pmid:18724234
|
Opelz G and Döhler B |
Effect on kidney graft survival of reducing or discontinuing maintenance immunosuppression after the first year posttransplant. |
2008 |
Transplantation |
pmid:18698238
|
Gallon LG et al. |
Long-term renal transplant function in recipient of simultaneous kidney and pancreas transplant maintained with two prednisone-free maintenance immunosuppressive combinations: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus. |
2007 |
Transplantation |
pmid:17519781
|
Ochiai T et al. |
Studies of the effects of FK506 on renal allografting in the beagle dog. |
1987 |
Transplantation |
pmid:2447688
|
Ochiai T et al. |
Studies of the induction and maintenance of long-term graft acceptance by treatment with FK506 in heterotopic cardiac allotransplantation in rats. |
1987 |
Transplantation |
pmid:2447689
|
Inamura N et al. |
Prolongation of skin allograft survival in rats by a novel immunosuppressive agent, FK506. |
1988 |
Transplantation |
pmid:2447690
|
Pape E et al. |
Management of Tacrolimus-Telaprevir Drug-Drug Interaction in a Liver Transplant Patient With Hepatitis C Virus: Practical Considerations. |
2015 |
Transplantation |
pmid:26308424
|
Egli A et al. |
Comparison of the effect of standard and novel immunosuppressive drugs on CMV-specific T-cell cytokine profiling. |
2013 |
Transplantation |
pmid:23274966
|
Hu H et al. |
Effect of immunosuppressants on T-cell subsets observed in vivo using carboxy-fluorescein diacetate succinimidyl ester labeling. |
2003 |
Transplantation |
pmid:12698107
|
Hebert MF et al. |
Interpreting tacrolimus concentrations during pregnancy and postpartum. |
2013 |
Transplantation |
pmid:23274970
|
Gruessner RW et al. |
Donor-specific portal blood transfusion in intestinal transplantation: a prospective, preclinical large animal study. |
1998 |
Transplantation |
pmid:9701258
|
Fujishiro J et al. |
Immunologic benefits of longer graft in rat allogenic small bowel transplantation. |
2005 |
Transplantation |
pmid:15665767
|
Pascual J et al. |
Interaction between everolimus and tacrolimus in renal transplant recipients: a pharmacokinetic controlled trial. |
2010 |
Transplantation |
pmid:20335831
|
Raggi MC et al. |
Customized mycophenolate dosing based on measuring inosine-monophosphate dehydrogenase activity significantly improves patients' outcomes after renal transplantation. |
2010 |
Transplantation |
pmid:21076373
|
Sahara H et al. |
Beneficial effects of perioperative low-dose inhaled carbon monoxide on pulmonary allograft survival in MHC-inbred CLAWN miniature swine. |
2010 |
Transplantation |
pmid:21076382
|
Thai NL et al. |
Alemtuzumab induction and tacrolimus monotherapy in pancreas transplantation: One- and two-year outcomes. |
2006 |
Transplantation |
pmid:17198247
|
Min SI et al. |
CYP3A5 *1 allele: impacts on early acute rejection and graft function in tacrolimus-based renal transplant recipients. |
2010 |
Transplantation |
pmid:21076384
|
Chan L et al. |
Multicenter, randomized study of the use of everolimus with tacrolimus after renal transplantation demonstrates its effectiveness. |
2008 |
Transplantation |
pmid:18360262
|
Thai NL et al. |
Pancreas transplantation under alemtuzumab (Campath-1H) and tacrolimus: Correlation between low T-cell responses and infection. |
2006 |
Transplantation |
pmid:17198253
|
Saad ER et al. |
Successful treatment of BK viremia using reduction in immunosuppression without antiviral therapy. |
2008 |
Transplantation |
pmid:18360267
|
Ueki S et al. |
Control of allograft rejection by applying a novel nuclear factor-kappaB inhibitor, dehydroxymethylepoxyquinomicin. |
2006 |
Transplantation |
pmid:17198266
|
Bendahan J et al. |
The effect of administration of FK506 on delayed regeneration in flushed partially hepatectomized livers. |
1994 |
Transplantation |
pmid:7511255
|
Chavin KD et al. |
Anti-CD2 monoclonal antibodies synergize with FK506 but not with cyclosporine or rapamycin to induce tolerance. |
1994 |
Transplantation |
pmid:7511258
|
Ricordi C et al. |
In vivo effect of FK506 on human pancreatic islets. |
1991 |
Transplantation |
pmid:1716797
|
Katz IA et al. |
Comparison of the effects of FK506 and cyclosporine on bone mineral metabolism in the rat. A pilot study. |
1991 |
Transplantation |
pmid:1716801
|
Inomata Y et al. |
The evolution of immunosuppression with FK506 in pediatric living-related liver transplantation. |
1996 |
Transplantation |
pmid:8600632
|
Gruber SA and Doshi MD |
Conversion to sirolimus in African American renal allograft recipients undergoing early steroid withdrawal: intermediate-term risks and benefits. |
2010 |
Transplantation |
pmid:20440195
|
Burger CI et al. |
Case report: drug interaction between tacrolimus and amiodarone with QT prolongation. |
2010 |
Transplantation |
pmid:20440199
|
Wong W et al. |
2005 immunosuppressive strategies in kidney transplantation: which role for the calcineurin inhibitors? |
2005 |
Transplantation |
pmid:16082321
|
Krämer BK et al. |
Tacrolimus-based, steroid-free regimens in renal transplantation: 3-year follow-up of the ATLAS trial. |
2012 |
Transplantation |
pmid:22858806
|
Vadivel N et al. |
Tacrolimus dose in black renal transplant recipients. |
2007 |
Transplantation |
pmid:17460575
|